Literature DB >> 14961900

Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.

John P Arlette1, Martin J Trotter.   

Abstract

Squamous cell carcinoma in situ (SCCIS) of the skin is a problem commonly dealt with by dermatologists. The classic presentation, originally described by Bowen, is easily recognized, but presentation on some anatomical surfaces may be associated with less than typical features. Major aetiological factors for this disease are UV light, human papillomavirus infection and immunosuppression. The natural course of SCCIS is usually prolonged, with treatment being appropriate, but not urgent. The choice of therapy requires consideration of the location of the lesion, and a desire for a high cure rate without causing loss of form, function or cosmesis. The immunomodulatory agent imiquimod has offered a significant advance for the topical treatment of SCCIS. Our improved understanding of the underlying biology of SCCIS permits us to make rational choices of treatment. In the future we may be able to determine which of these lesions may progress to invasive disease, and help us select the most effective therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961900     DOI: 10.1111/j.1440-0960.2004.00025.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  7 in total

1.  Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.

Authors:  Selin Tokez; Marlies Wakkee; Marieke Louwman; Eline Noels; Tamar Nijsten; Loes Hollestein
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

2.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

Review 3.  Cross-Disease Transcriptomics: Unique IL-17A Signaling in Psoriasis Lesions and an Autoimmune PBMC Signature.

Authors:  William R Swindell; Mrinal K Sarkar; Yun Liang; Xianying Xing; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2016-05-17       Impact factor: 8.551

Review 4.  Interventions for cutaneous Bowen's disease.

Authors:  Fiona J Bath-Hextall; Rubeta N Matin; David Wilkinson; Jo Leonardi-Bee
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

5.  Bowen's Disease of the Nipple.

Authors:  Miyuki Kitahara; Yasuo Hozumi; Akie Watanabe; Tatsuo Iijima
Journal:  Case Rep Oncol       Date:  2018-09-07

Review 6.  Bowen's Disease.

Authors:  Vijayasankar Palaniappan; Kaliaperumal Karthikeyan
Journal:  Indian Dermatol Online J       Date:  2022-03-03

7.  Squamous-cell Carcinoma Arises in Red Parts of Multicolored Tattoo within Months.

Authors:  Felix Julian Paprottka; Stiliano Bontikous; Jörn A Lohmeyer; Detlev Hebebrand
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.